Dolby Laboratories, Inc. (DLB)

$79.16

+0.35

(+0.44%)▲

Market is closed - opens 7 PM, 24 Apr 2024

Insights on Dolby Laboratories, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 290.56M → 315.57M (in $), with an average increase of 7.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 9.18M → 66.98M (in $), with an average increase of 86.3% per quarter

  • Vs CTAS

    In the last 1 year, Cintas Corporation has given 44.6% return, outperforming this stock by 51.1%

  • Vs CTAS

    In the last 3 years, Cintas Corporation has given 88.0% return, outperforming this stock by 109.1%

Performance

  • $78.73
    $79.56
    $79.16
    downward going graph

    0.54%

    Downside

    Day's Volatility :1.04%

    Upside

    0.5%

    downward going graph
  • $75.33
    $90.04
    $79.16
    downward going graph

    4.84%

    Downside

    52 Weeks Volatility :16.34%

    Upside

    12.08%

    downward going graph

Returns

PeriodDolby Laboratories, Inc.Sector (Technology)Index (Russel 2000)
3 Months
-8.1%
-3.8%
0.0%
6 Months
-1.49%
18.4%
0.0%
1 Year
-5.59%
31.5%
-1.3%
3 Years
-21.07%
36.1%
-22.1%

Highlights

Market Capitalization
7.5B
Book Value
$24.47
Dividend Share
1.14
Dividend Yield
1.53%
Earnings Per Share (EPS)
1.92
PE Ratio
40.72
PEG Ratio
2.08
Wall Street Target Price
98.0
Profit Margin
14.7%
Operating Margin TTM
22.91%
Return On Assets TTM
5.31%
Return On Equity TTM
8.15%
Revenue TTM
1.3B
Revenue Per Share TTM
13.39
Quarterly Revenue Growth YOY
-5.800000000000001%
Gross Profit TTM
1.1B
EBITDA
322.6M
Diluted Eps TTM
1.92
Quarterly Earnings Growth YOY
-0.16
EPS Estimate Current Year
3.71
EPS Estimate Next Year
3.93
EPS Estimate Current Quarter
0.86
EPS Estimate Next Quarter
1.17

Analyst Recommendation

Buy
    62%Buy
    37%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Dolby Laboratories, Inc.(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
5
6
Hold
3
3
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 23.8%

Current $79.16
Target $98.00

Company Financials

FY18Y/Y Change
Revenue
1.2B
↑ 8.37%
Net Income
122.2M
↓ 39.42%
Net Profit Margin
10.43%
↓ 8.23%
FY19Y/Y Change
Revenue
1.2B
↑ 5.95%
Net Income
255.2M
↑ 108.72%
Net Profit Margin
20.55%
↑ 10.12%
FY20Y/Y Change
Revenue
1.2B
↓ 6.43%
Net Income
231.4M
↓ 9.32%
Net Profit Margin
19.91%
↓ 0.64%
FY21Y/Y Change
Revenue
1.3B
↑ 10.28%
Net Income
310.2M
↑ 34.09%
Net Profit Margin
24.21%
↑ 4.3%
FY22Y/Y Change
Revenue
1.3B
↓ 2.14%
Net Income
184.1M
↓ 40.66%
Net Profit Margin
14.68%
↓ 9.53%
FY23Y/Y Change
Revenue
1.0B
↓ 19.51%
Net Income
191.5M
↑ 4.01%
Net Profit Margin
18.97%
↑ 4.29%
Q3 FY22Q/Q Change
Revenue
278.2M
↓ 3.93%
Net Income
27.8M
↓ 29.9%
Net Profit Margin
9.98%
↓ 3.69%
Q4 FY22Q/Q Change
Revenue
334.9M
↑ 20.39%
Net Income
79.4M
↑ 185.97%
Net Profit Margin
23.7%
↑ 13.72%
Q1 FY23Q/Q Change
Revenue
375.9M
↑ 12.23%
Net Income
95.7M
↑ 20.56%
Net Profit Margin
25.46%
↑ 1.76%
Q2 FY23Q/Q Change
Revenue
298.4M
↓ 20.62%
Net Income
16.4M
↓ 82.86%
Net Profit Margin
5.5%
↓ 19.96%
Q3 FY23Q/Q Change
Revenue
290.6M
↓ 2.62%
Net Income
9.2M
↓ 43.98%
Net Profit Margin
3.16%
↓ 2.34%
Q4 FY23Q/Q Change
Revenue
315.6M
↑ 8.61%
Net Income
67.0M
↑ 629.16%
Net Profit Margin
21.23%
↑ 18.07%
FY18Y/Y Change
Total Assets
2.7B
↑ 4.96%
Total Liabilities
463.2M
↑ 18.84%
FY19Y/Y Change
Total Assets
2.8B
↑ 6.11%
Total Liabilities
508.7M
↑ 9.84%
FY20Y/Y Change
Total Assets
2.9B
↑ 3.39%
Total Liabilities
478.9M
↓ 5.86%
FY21Y/Y Change
Total Assets
3.1B
↑ 6.46%
Total Liabilities
501.5M
↑ 4.71%
FY22Y/Y Change
Total Assets
2.7B
↓ 13.4%
Total Liabilities
438.5M
↓ 12.55%
FY23Y/Y Change
Total Assets
3.0B
↑ 10.79%
Total Liabilities
607.6M
↑ 38.55%
Q3 FY22Q/Q Change
Total Assets
2.7B
↓ 7.89%
Total Liabilities
438.5M
↓ 4.75%
Q4 FY22Q/Q Change
Total Assets
2.7B
↑ 2.19%
Total Liabilities
456.0M
↑ 3.98%
Q1 FY23Q/Q Change
Total Assets
2.8B
↑ 3.19%
Total Liabilities
480.1M
↑ 5.29%
Q2 FY23Q/Q Change
Total Assets
3.0B
↑ 6.06%
Total Liabilities
625.2M
↑ 30.21%
Q3 FY23Q/Q Change
Total Assets
3.0B
↓ 0.94%
Total Liabilities
607.6M
↓ 2.82%
Q4 FY23Q/Q Change
Total Assets
2.9B
↓ 1.48%
Total Liabilities
573.2M
↓ 5.66%
FY18Y/Y Change
Operating Cash Flow
352.2M
↓ 5.08%
Investing Cash Flow
78.1M
↓ 148.28%
Financing Cash Flow
-133.6M
↑ 33.51%
FY19Y/Y Change
Operating Cash Flow
327.7M
↓ 6.96%
Investing Cash Flow
-56.2M
↓ 172.01%
Financing Cash Flow
-385.3M
↑ 188.32%
FY20Y/Y Change
Operating Cash Flow
343.8M
↑ 4.94%
Investing Cash Flow
134.4M
↓ 338.98%
Financing Cash Flow
-207.8M
↓ 46.07%
FY21Y/Y Change
Operating Cash Flow
447.8M
↑ 30.22%
Investing Cash Flow
-44.9M
↓ 133.42%
Financing Cash Flow
-252.5M
↑ 21.53%
FY22Y/Y Change
Operating Cash Flow
318.6M
↓ 28.85%
Investing Cash Flow
-295.9M
↑ 559.02%
Financing Cash Flow
-610.6M
↑ 141.79%
FY23Y/Y Change
Operating Cash Flow
282.1M
↓ 11.46%
Investing Cash Flow
54.2M
↓ 118.32%
Financing Cash Flow
-194.0M
↓ 68.22%
Q3 FY22Q/Q Change
Operating Cash Flow
51.3M
↓ 70.27%
Investing Cash Flow
-295.9M
↑ 3526.21%
Financing Cash Flow
-242.4M
↑ 22.52%
Q4 FY22Q/Q Change
Operating Cash Flow
56.4M
↑ 9.91%
Investing Cash Flow
28.3M
↓ 109.56%
Financing Cash Flow
-90.1M
↓ 62.84%
Q1 FY23Q/Q Change
Operating Cash Flow
104.5M
↑ 85.37%
Investing Cash Flow
23.6M
↓ 16.66%
Financing Cash Flow
-67.1M
↓ 25.53%
Q2 FY23Q/Q Change
Operating Cash Flow
121.1M
↑ 15.87%
Investing Cash Flow
22.0M
↓ 6.59%
Financing Cash Flow
-36.8M
↓ 45.12%
Q3 FY23Q/Q Change
Operating Cash Flow
85.0M
↓ 29.81%
Investing Cash Flow
-19.7M
↓ 189.47%
Financing Cash Flow
-42.8M
↑ 16.22%

Technicals Summary

Sell

Neutral

Buy

Dolby Laboratories, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Dolby Laboratories, Inc.
Dolby Laboratories, Inc.
-5.3%
-1.49%
-5.59%
-21.07%
22.85%
Copart, Inc.
Copart, Inc.
-6.79%
20.72%
35.71%
71.0%
223.72%
Thomson Reuters Corp.
Thomson Reuters Corp.
-1.68%
24.19%
11.16%
66.51%
155.67%
Global Payments Inc.
Global Payments Inc.
-6.35%
14.2%
14.77%
-42.73%
-13.56%
Rb Global Inc
Rb Global Inc
-3.87%
16.33%
25.53%
15.26%
110.46%
Cintas Corporation
Cintas Corporation
4.62%
33.14%
45.21%
88.0%
211.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Dolby Laboratories, Inc.
Dolby Laboratories, Inc.
40.72
40.72
2.08
3.71
0.08
0.05
0.02
24.47
Copart, Inc.
Copart, Inc.
37.77
37.77
3.12
1.44
0.23
0.15
NA
7.06
Thomson Reuters Corp.
Thomson Reuters Corp.
26.4
26.4
3.64
3.58
0.23
0.06
0.01
24.18
Global Payments Inc.
Global Payments Inc.
32.95
32.95
0.65
11.59
0.04
0.03
0.01
88.33
Rb Global Inc
Rb Global Inc
69.82
69.82
2.67
3.19
0.06
0.06
0.01
27.44
Cintas Corporation
Cintas Corporation
45.96
45.96
3.79
14.96
0.38
0.14
0.01
41.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Dolby Laboratories, Inc.
Dolby Laboratories, Inc.
Buy
$7.5B
22.85%
40.72
14.7%
Copart, Inc.
Copart, Inc.
Buy
$50.8B
223.72%
37.77
33.41%
Thomson Reuters Corp.
Thomson Reuters Corp.
Hold
$67.8B
155.67%
26.4
39.67%
Global Payments Inc.
Global Payments Inc.
Buy
$31.7B
-13.56%
32.95
10.22%
Rb Global Inc
Rb Global Inc
Buy
$13.3B
110.46%
69.82
5.61%
Cintas Corporation
Cintas Corporation
Buy
$67.5B
211.62%
45.96
15.98%

Institutional Holdings

  • Vanguard Group Inc

    6.69%

  • BlackRock Inc

    6.07%

  • Kayne Anderson Rudnick Investment Management LLC

    5.67%

  • Morgan Stanley - Brokerage Accounts

    5.12%

  • Ninety One UK Limited

    2.69%

  • ClearBridge Advisors, LLC

    2.53%

Corporate Announcements

  • Dolby Laboratories, Inc. Dividends March,2024

    In the quarter ending March,2024. Dolby Laboratories, Inc. has declared dividend of $0.3

    Read More

Company Information

we're the rain on the roof in a movie. the music flowing through your earbuds when you're at the gym. the footsteps lurking behind you in a video game. the voice of a colleague on a call who seems to be right next to you. the sight of a breathtakingly bright and vivid sunset on your tv. making experiences come alive through technology is what we do. it's been our mission since day one. it began with our founder, ray dolby, a visionary scientist and inventor. as a young engineer and music lover, he was driven to improve the listening experience. and with that simple motivation, plus countless hours of experimentation, he created a solution—a solution that was elegant and practical, highly sophisticated, and wholly devoted to the artist's vision. even as we've become a global company, dolby laboratories continues to reflect ray dolby's values. here, science meets art. and high tech goes far beyond computer code. founded in 1965 and headquartered in san francisco, dolby has grown into a l

Organization
Dolby Laboratories, Inc.
Employees
2246
CEO
Mr. Kevin J. Yeaman
Industry
Consumer Services

Discover More

FAQs